AI assistant
Novonesis AS Director's Dealing 2023
3377_rns_2023-01-27_e83597f1-9d5b-49b3-b5bc-e9ceabb1ac9b.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYM B.
January 27, 2023
Company announcement No. 4
Contact information
[email protected]
Tobias Cornelius Björklund
+45 3077 8682
[email protected]
Ludmila Cebanov
+45 3077 0554
[email protected]
Anders Enevoldsen
+45 5350 1453
[email protected]
Novozymes A/S
Krogshoejej 36
2880 Bagsvaerd
Denmark
Phone: +45 4446 0000
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 50 00 71 27 LEI: 529900T6WNZXD2R3JW3B
Trading by management and close relations of management. Company announcement No. 4
2/3
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
|---|---|---|
| a) | Name | Jørgen Buhl Rasmussen |
| 2. | Reason for the notification | |
| a) | Position/status | Chair of the Board of Directors |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auc- tion monitor | |
| a) | Name | Novozymes A/S |
| b) | LEI | 529900T6WNZXD2R3JW38 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | |
| Identification code | Shares | |
| ISIN DK0060336014 | ||
| b) | Nature of the transaction | Purchase of shares |
| c) | Price(s) and volume(s) | Price(s) Volume(s) |
| DKK 347 2,900 shares | ||
| d) | Aggregated information | |
| - Aggregated volume | ||
| - Price | Number of shares: 2,900 | |
| Average price, DKK: 347 | ||
| Transaction value, DKK: 1,006,300 | ||
| e) | Date of transaction | 2023-01-27 |
| f) | Place of the transaction | Copenhagen Stock Exchange |
Rethink Tomorrow
novozymes
Trading by management and close relations of management. Company announcement No. 4
3/3
| CPH | XCSE | 731 | 347 | 20230127 |
|---|---|---|---|---|
| 09:00:04.561847 | ||||
| 20230127 | ||||
| CPH | XCSE | 680 | 347 | 09:00:04.561847 |
| 20230127 | ||||
| CPH | XCSE | 593 | 347 | 09:00:04.561847 |
| 20230127 | ||||
| CPH | XCSE | 406 | 347 | 09:00:04.561847 |
| 20230127 | ||||
| CPH | XCSE | 306 | 347 | 09:00:04.561847 |
| 20230127 | ||||
| CPH | XCSE | 184 | 347 | 09:00:04.561847 |
Rethink Tomorrow
novozymes